Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jonathan Segal and Nicholas Kennedy.
Jonathan Segal
Connection Strength
0.231
Nicholas Kennedy
  1. Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. Aliment Pharmacol Ther. 2021 06; 53(11):1236-1240.
    View in: PubMed
    Score: 0.059
  2. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021 04; 6(4):271-281.
    View in: PubMed
    Score: 0.058
  3. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol. 2021 03; 6(3):218-224.
    View in: PubMed
    Score: 0.058
  4. Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID-19 in the United Kingdom. Aliment Pharmacol Ther. 2020 Sep; 52(5):937-939.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.